Medically reviewed by Lindsay Cook, PharmD If you have HER2-positive breast cancer, your options for treatment will depend on ...

HER2-positive breast cancer HER2 is a protein that helps control the growth of healthy breast cells. HER2/neu is a gene that acts like an on/off switch to make HER2. About 1 out of every 5 cases of ...

Studies have shown that Asian American women may be prone to a more aggressive type of breast cancer, caused by the HER2/neu protein, than women from other racial groups. AAPI women collectively ...

But because her tumor expressed high levels of Her2/neu, it was less responsive to tamoxifen, and after the five years were up, she was faced with a dilemma. "I started thinking, what do I want to do?

The HER2/neu-trastuzumab (Herceptin) biomarker stories are a dream to attain as a biomarker that relates symptoms to mechanism, and for most diseases they will remain a dream because such easy ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

Or, if aggressive cancer features are identified later on through tumor testing called biomarker testing, like HER2 neu expression testing for breast cancer cells, explains Dr. Monique Gary ...

and the HER2/neu marker. These triple negative breast tumours are more aggressive and result in higher breast cancer mortality rates. Explanations for the delayed presentation among women in Ghana ...

a FDA = Food and Drug Administration; CYP2C9 = cytochrome P-450 isoenzyme 2C9; VKORC1 = vitamin K epoxide reductase complex subunit 1; UGT1A1 = uridine diphosphate-glucuronosyltransferase 1A1 ...

Studies have shown that Asian American women may be prone to a more aggressive type of breast cancer, caused by the HER2/neu protein, than women from other racial groups. Asian American and ...